Skip to main contentAI and Advanced
/
KIMS · NSEBSE SENSEX74,383.76+0.06%BSE |
NIFTY 5023,272.2+0.24%NSE |
NIFTY BANK56,105.25-0.33%NSE |
NIFTY IT29,049.6-0.13%NSE |
NIFTY AUTO27,184.1+1.08%NSE |
NIFTY FMCG45,651.25+0.20%NSE |
NIFTY PHARMA26,482.95+1.29%NSE |
NIFTY 50022,645.45+0.50%NSE |
KI
NSE · Equity shares · Healthcare Facilities-1.60 · -0.21%
Krishna Institute of Medical Sciences Ltd KIMS
NSE:INR 765.05
BSE:INR 765.45
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for KIMS
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 766.65
Day rangeINR 758.5 — INR 775
52-week rangeINR 575.55 — INR 858.15
Volume3.10 L
Market cap34,158.94
P/E159.73
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)3,904.6
Net Income (INR Cr)241.4
Rev Growth (5 Year %)24.04
EPS Growth (5 Year %)3.7
P/E Ratio159.73
EPS6.23
Research path: Interpret Krishna Institute of Medical Sciences Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
KIMSKrishna Institute of Medical Sciences Ltd1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 7,758.7 | 5,736 | 3,852.02 |
| Cash Equivalents | 74.7 | 6.7 | 15.75 |
| Other Liabilities Total | 255.9 | 147 | 33.92 |
| Accrued Expenses | 32.6 | 47.2 | 40.05 |
| Long Term Debt | 2,672.6 | 1,654.1 | 927.64 |
| Common Stock Total | 80 | 80 | 80.03 |
| Other Current Assets Total | 56.8 | 9.8 | 4.78 |
| Total Assets | 7,758.7 | 5,736 | 3,852.02 |
| Current Portof LT Debt/Capital Leases | 615.5 | 140.2 | 38.31 |
| Total Equity | 2,247.4 | 2,137.8 | 1,828.36 |
| Long Term Investments | 165.9 | 77.1 | 74.53 |
| Retained Earnings(Accumulated Deficit) | 2,167.4 | 1,023.8 | 714.29 |
| Total Common Shares Outstanding | 40.01 | 40.01 | 40.01 |
| Tangible Book Valueper Share Common Eq | 46.28 | 43.27 | 36.38 |
| Goodwill Net | 338.6 | 338.6 | 308.01 |
| Total Liabilities | 5,511.3 | 3,598.2 | 2,023.66 |
| Total Debt | 4,252.9 | 2,556.7 | 1,355.33 |
| Short Term Investments | 82.6 | 45.7 | 85.09 |
| Cashand Short Term Investments | 157.3 | 101.7 | 131.98 |
| Total Receivables Net | 626.4 | 487.4 | 330.75 |
| Deferred Income Tax | 68 | 46.8 | 46.28 |
| Accounts Receivable-Trade Net | 554.2 | 434.8 | 320.63 |
| Property/Plant/Equipment Total-Net | 5,920.7 | 4,156 | 2,661.34 |
| Minority Interest | 311.1 | 281 | 264.88 |
| Total Current Liabilities | 1,238.9 | 836.2 | 452.29 |
| Total Inventory | 96.9 | 89.2 | 72.2 |
| Accounts Payable | 322.8 | 269.1 | 197.15 |
| Other Currentliabilities Total | 268 | 250.4 | 86.06 |
| Total Long Term Debt | 3,637.4 | 2,287.2 | 1,226.3 |
| Intangibles Net | 57 | 67.7 | 64.65 |
| Other Long Term Assets Total | 270.7 | 128.2 | 68.33 |
| Note Receivable-Long Term | 68.4 | 271.1 | 127.72 |
| Total Current Assets | 937.4 | 697.3 | 547.44 |
| Capital Lease Obligations | 964.8 | 633.1 | 298.65 |
| Accumulated Depreciation Total | Not available | -638.9 | -517.07 |
| Prepaid Expenses | Not available | 9.2 | 7.72 |
| Additional Paid-In Capital | Not available | 1,034 | 1,034.04 |
| Cash | Not available | 49.3 | 31.14 |
| Property/Plant/Equipment Total-Gross | Not available | 3,581.1 | 2,578.32 |
| Notes Payable/Short Term Debt | Not available | 129.3 | 90.72 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %68.15
Margins
Operating Margin 12m11.66
Operating Margin 5y Avg19.06
Net Profit Margin 12m4.61
Net Profit Margin 5y12.81
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio8.75
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk34.49
Analyst consensus
ConsensusBuy
Consensus score1.92
Analyst opinions12
Strong Sell count0
Sell count2
Hold count0
Buy count5
Strong Buy count5
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 32.50%
- FII
- 14.75%
- MF
- 28.52%
- Other
- 24.23%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
IFC invests about $15.8m in Indian hospital operator KIMS - DealStreetAsiaMarket news · 22 Jul 2026, 8:24 am
IFC invests about $15.8m in Indian hospital operator KIMS DealStreetAsia
KIMS Kondapur Removes Rare Tumour In A High-Risk 10-Hour Surgery - ETV BharatMarket news · 15 Jul 2026, 7:38 pm
KIMS Kondapur Removes Rare Tumour In A High-Risk 10-Hour Surgery ETV Bharat
KIMS approves preferential warrant issue in EGM - scanx.tradeMarket news · 11 Jul 2026, 12:30 pm
KIMS approves preferential warrant issue in EGM scanx.trade
KIMS Issues Corrigendum to EGM Notice on Preferential Share Issue - The Globe and MailMarket news · 5 Jul 2026, 12:30 pm
KIMS Issues Corrigendum to EGM Notice on Preferential Share Issue The Globe and Mail
Cyril Amarchand Mangaldas advises on the QIP of Krishna Institute of Medical Sciences Ltd. - SCC OnlineMarket news · 29 Jun 2026, 1:00 pm
Cyril Amarchand Mangaldas advises on the QIP of Krishna Institute of Medical Sciences Ltd. SCC Online
KIMS Forecast — Price Target — Prediction for 2027 - TradingViewMarket news · 25 Jun 2026, 7:22 pm
KIMS Forecast — Price Target — Prediction for 2027 TradingView
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingEGM
- board MeetingsInter-alia, to consider 1. Proposal for raising of funds by way of issuance of one or more instruments/ securities or through any other permissible mode. 2. Other business matters .
- board MeetingsAudited Results
- annual General MeetingPOM
- board MeetingsInter-alia, to consider 1. Proposal for raising of funds by way of issuance of equity shares, in one or more tranches or rights issue or through any other permissible mode. 2. Other business matters.
- board MeetingsQuarterly Results
- annual General MeetingPOM
Rusaka Markets Community
Discussion and sentiment for Krishna Institute of Medical Sciences Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Krishna Institute of Medical Sciences Ltd is an India-based company, which is primarily engaged in the business of rendering medical and healthcare services. The Company's departments include accident, Alzheimer center, andrology and Male infertility center, pediatric obesity, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal centre, pediatric surgical centre, female urology centre, fertility centre, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, 4D Scan for pregnancy, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Company's institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- KIMS
- BSE Code
- 543308
Questions
Stock FAQ
What is the symbol and ISIN of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has the symbol KIMS and ISIN - INE967H01025.
What is the current price of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd is currently trading at INR 765.05.
What are the year high and year low of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a year high of INR 858.15 and a year low of INR 575.55.
What is the market capitalization of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a market capitalization of INR 34,158.94 crore.
What is the P/E ratio of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a P/E ratio of 159.73.
What is the dividend yield of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a dividend yield of 0.00%.
How is the financial performance of Krishna Institute of Medical Sciences Ltd based on revenue, net income, and EPS?
Krishna Institute of Medical Sciences Ltd has revenue of INR 3,904.60 crore, net income of INR 241.40 crore, and EPS of INR 5.27.
What is the book value of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a book value of NA.
What is the debt-to-equity ratio of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Krishna Institute of Medical Sciences Ltd?
Krishna Institute of Medical Sciences Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 8.75.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.